Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	96.28	59.82	175.53	20.53	86.51	24.93
Short-Term Investments	131.44	268.31	71	205.91	39	20
Cash & Short-Term Investments	227.72	328.13	246.53	226.44	125.51	44.93
Cash Growth	-33.86%	33.10%	8.87%	80.42%	179.34%	23.96%
Accounts Receivable	17.24	-	-	-	-	-
Other Current Assets	8.58	6.51	4.41	1.25	1.57	1.4
Total Current Assets	253.55	334.64	250.94	227.69	127.08	46.33
Net Property, Plant & Equipment	4.25	5.11	0.36	0.95	0.39	0.97
Other Long-Term Assets	14.07	2.61	3.36	2	0.05	0.17
Total Assets	271.87	342.36	254.67	230.63	127.51	47.46

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	1.14	4.32	1.51	0.79	1.56	1.54
Accrued Expenses	16.48	13.43	9.71	7.69	3.28	4.2
Current Portion of Leases	1.4	1.38	0.33	0.58	0.37	0.65
Unearned Revenue	4.5	-	-	-	-	-
Total Current Liabilities	23.52	19.13	11.55	9.06	5.2	6.39
Long-Term Leases	3.06	3.97	-	0.36	-	0.4
Other Long-Term Liabilities	12.04	-	-	-	-	-
Total Long-Term Liabilities	15.1	3.97	-	0.36	-	0.4
Total Liabilities	38.61	23.1	11.55	9.42	5.2	6.79

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Preferred Stock	95.32	95.32	95.32	96.4	96.4	-
Common Stock	0.06	0.06	0.04	0.03	0.01	0
Additional Paid-in Capital	911.01	898.52	728.29	632.51	481.71	301.56
Accumulated Other Comprehensive Income	0.06	0.16	-	-0.08	-	-
Retained Earnings	-773.2	-674.79	-580.53	-507.64	-455.81	-260.9
Shareholders' Equity	233.25	319.26	243.12	221.22	122.31	40.67
Total Liabilities & Equity	271.87	342.36	254.67	230.63	127.51	47.46

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	4.46	5.35	0.33	0.94	0.37	1.05
Net Cash (Debt)	223.27	322.78	246.2	225.5	125.14	43.88
Net Cash Growth	-34.07%	31.10%	9.18%	80.19%	185.17%	29.10%
Net Cash Per Share	3.85	5.75	8.17	15.42	14.02	14.35
Book Value	233.25	319.26	243.12	221.22	122.31	40.67
Book Value Per Share	4.02	5.68	8.07	15.13	13.70	13.30
Tangible Book Value	233.25	319.26	243.12	221.22	122.31	40.67
Tangible Book Value Per Share	4.02	5.68	8.07	15.13	13.70	13.30

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Sep 30, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error